@Brand, no CEO has a business plan to be taken over. Therein lies disaster!
If you are waiting for a takeover bid, you will take you eye off the ball and will make mistakes. For me, I want my BOD to use all the company's assets to the best advantage and to enhance shareholder value over time. We seem to have a very active and engaged BOD who are doing exactly that. Yes, there may be a bid sometime, but SNG will be in a strong position with the management in place to fully market our drug. This will be an additional asset available to any would be bidder and it has to be value enhancing.
@Treacle, it's more of a rumour unless and until formally confirmed or denied by NIH. As such it isn't price sensitive information available to the BOD, simply a rumour.
Synairgen did respond, however through Twitter. It's what I call a 'soft RNS' - informing on something outside their control and which they are unable to manage. Yes, it may be influential on pricing, but a rumour doesn't always force the company to issue a full RNS.
I did like the 'soft RNS', though! Lots of lines to read in between....
The satellite images help illustrate what they are up against. The nice shinny white roads ave been done for a reason. Copious amounts of waste rock from the box cut has been used for this. Much easier to drain and maintain as opposed to cleared compacted dirt.